Corgenix to Host Conference Call to Discuss Fiscal 2012 Results
DENVER--(BUSINESS WIRE)-- Corgenix Medical Corporation (OTC BB: CONX), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, September 27, 2012, at 4:00 PM EDT to discuss the company's financial and operating performance for its fiscal year ended June 30, 2012, and the status of the company's product development and marketing activities.
Corgenix invites all those interested in hearing management's discussion of the annual results to join the call by dialing:
U.S. attendees: (800) 862-9098
International attendees: +1 785 424 1051
Conference code is: CORGENIX
A question-and-answer session will follow the presentation by Corgenix management.
A replay will be available for 30 days following the call by dialing (800) 388-6509 for U.S. participants and +1 402 220 1111 for international participants.
About Corgenix Medical Corporation
Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network. More information is available at www.corgenix.com.
Corgenix Medical Corp.
William Critchfield, 303-453-8903
Senior VP Operations and Finance and CFO
Armada Medical Marketing
Dan Snyders, 303-623-1190 x 230
Vice President, Public Relations Supervisor
KEYWORDS: United States North America Colorado
The article Corgenix to Host Conference Call to Discuss Fiscal 2012 Results originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.